Our lab creates in vitro models of human neurodegenerative diseases by converting patients’ skin fibroblasts into disease-affected neural cells. This enables us to screen thousands of drug-like compounds in search of potential therapeutics that slow or stop the degeneration of these cells in petri dishes — and eventually in patients.
- Justin Ichida publishes research update in The Hollywood Reporter February 20, 2018
- The toxic relationship between ALS and frontotemporal dementia February 5, 2018
- The Broad Foundation awards $1 million to early-stage stem cell research projects September 29, 2017